About Immunoadoptive Cell Therapy Private Limited
Data last updated: 23 December 2025
Immunoadoptive Cell Therapy Private Limited is a private limited company based in Thane, Maharashtra, India, recognised as a startup by DPIIT. It specialises in preventive healthcare, a part of the broader healthcare sector. Incorporated on 08 October 2018, the company has been in operation for over 8 years.
Registered with ROC Mumbai under CIN U74999MH2018PTC315497.
Capital: an authorised share capital of ₹49 Lakh and a paid-up capital of ₹2.01 Lakh. It is led by directors including Shirish Arya and Atharva Ajay Karulkar.
Last AGM: 12 June 2025. Financial statements filed for year ended 31 March 2025. Office: Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.57 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 69 employees as per the latest available data.
The company is associated with 1 brand - Immunoact.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website immunoact.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No.D – 222/26 Ttc Industrial Area, Midc Village Shiravane Navi Mumbai, Thane, Maharashtra, India – 400706
-
IndustryHealthcare, Preventive Health Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited operates one associated brand: ImmunoACT. These brands represent Immunoadoptive Cell Therapy Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Cell therapies for cancer treatment are developed. | immunoact.com |
Competitors & Alternatives of Immunoadoptive Cell Therapy Private Limited
Brands and companies operating in the same space as Immunoadoptive Cell Therapy Private Limited include Orca Bio, Ossium Health, Adicet Bio and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Orca Bio
|
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | Menlo Park, United States, United States | 2016 |
Ossium Health
|
Ossium Health is focused on bioengineering for improved health. | San Francisco, United States, United States | 2016 |
Adicet Bio
|
Immune cell therapies for cancer treatment are developed. | Menlo Park, United States, United States | 2014 |
Auron Therapeutics
|
Developer of cancer therapeutics for the treatment of blood cancer | Wellesley, United States, United States | 2018 |
Syros Pharmaceuticals
|
Small molecule therapeutics for cancer and genetic diseases are developed. | Watertown, United States, United States | 2012 |
Nordic Nanovector
|
Antibody radionuclide conjugates are developed for haematological cancers. | Oslo, Norway, Norway | 2009 |
Kiadis Pharma
|
Therapeutic solutions for hematopoietic stem cell transplants are developed. | Amsterdam, Netherlands, Netherlands | 1997 |
Business Activity of Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Immunoadoptive Cell Therapy Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited is audited by Deloitte Haskins & Sells for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells | Locked | Locked | Locked |
Complete auditor history for Immunoadoptive Cell Therapy Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited is currently managed by 6 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Shirish Arya
Also directs:
Immunoact Research Foundation
|
Director | 06 Aug 2021 | 5 Years 0 Months | Current |
| Atharva Ajay Karulkar | Director | 29 Oct 2021 | 4 Years 9 Months | Current |
|
Shalini Rahul Purwar
Also directs:
Immunoact Research Foundation
|
Whole-Time Director | 08 Oct 2018 | 7 Years 10 Months | Current |
|
Rahul Purwar
Also directs:
Immunoact Research Foundation, Advy Biosciences Private Limited
|
Director | 08 Oct 2018 | 7 Years 10 Months | Current |
|
Chava Satyanarayana
Also directs:
Laurus Labs Limited, Laurus Bio Private Limited, Krka Pharma Private Limited and 1 more
|
Nominee Director | 09 Dec 2021 | 4 Years 8 Months | Current |
|
Ravindranath Kancherla
Also directs:
Hygieia Global Health Services Llp, Laurus Labs Limited, Arunachalam Automotives Private Limited and 5 more
|
Nominee Director | 09 Dec 2021 | 4 Years 8 Months | Current |
Financials of Immunoadoptive Cell Therapy Private Limited FY 2025 filings available
Immunoadoptive Cell Therapy Private Limited reported revenue of ₹67.57 Cr (up 510.00% YoY) for FY 2025.
Ten-year financial statements for Immunoadoptive Cell Therapy Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Immunoadoptive Cell Therapy Private Limited
Shareholding and ownership data for Immunoadoptive Cell Therapy Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited has a workforce of 69 employees as of Apr 07, 2024.
Employee and EPFO history for Immunoadoptive Cell Therapy Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Immunoadoptive Cell Therapy Private Limited
GST registrations and filing compliance for Immunoadoptive Cell Therapy Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Immunoadoptive Cell Therapy Private Limited
Credit ratings, litigation, and regulatory alerts for Immunoadoptive Cell Therapy Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Immunoadoptive Cell Therapy Private Limited
MSME payment history for Immunoadoptive Cell Therapy Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Immunoadoptive Cell Therapy Private Limited
Corporate group structure for Immunoadoptive Cell Therapy Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Immunoadoptive Cell Therapy Private Limited
MCA filings and documents for Immunoadoptive Cell Therapy Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Immunoadoptive Cell Therapy Private Limited
Frequently Asked Questions about Immunoadoptive Cell Therapy Private Limited
Immunoadoptive Cell Therapy Private Limited is an active private limited company in the healthcare sector based in Thane, Maharashtra, India. It was incorporated on 08 October 2018 (8+ years old) and is registered under CIN U74999MH2018PTC315497. The company has 69 employees.
Immunoadoptive Cell Therapy Private Limited reported revenue of ₹67.57 Cr for FY 2025 (up 510.00% YoY).
The current directors of Immunoadoptive Cell Therapy Private Limited are:
- Shirish Arya - Director
- Atharva Ajay Karulkar - Director
- Shalini Rahul Purwar - Whole-Time Director
- Rahul Purwar - Director
- Chava Satyanarayana - Nominee Director
- Ravindranath Kancherla - Nominee Director
The primary industry of Immunoadoptive Cell Therapy Private Limited is healthcare. The company specifically operates in preventive health services. The company is currently active in this sector.
Yes, Immunoadoptive Cell Therapy Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Immunoadoptive Cell Therapy Private Limited can be reached at the registered office: Plot No.D – 22226 Ttc Industrial Area, Midc Village Shiravane Navi Mumbai, Thane, Maharashtra, India – 400706, or through the website immunoact.com.